Ecology, life history, and fisheries potential of the flathead lobster (Thenus orientalis) in the Arabian Gulf

This study, which included examination of the distribution and life history and a stock assessment of the flathead lobster (Thenus orientalis), is the first of its kind in the waters of Saudi Arabia in the Arabian Gulf, also known as the Persian Gulf. The flathead lobster is widely distributed in this region, although it is more abundant in the central and northern Arabian Gulf. Carapace lengths at 50% and 95% maturity are 59 and 65 mm for females and 58 and 71 mm for males. The fecundity of 4 berried females ranged from 26,000 to 76,000 eggs per spawning, and the fertilization rate exceeded 97%. Length-frequency data were consistent with just 2 cohorts, indicating that this species has a short life span and high growth coefficient (K=0.846 year(-1)). Large fishing boats (called dhows) accounted for more than 98% of the total landings. Estimates of natural mortality rates from use of generalized depletion models have high statistical precision and a magnitude compatible with short life history. In addition, abundance levels estimated with the depletion model are sufficient to support a sustainable small-scale fishery either as bycatch of shrimp trawlers or as a resource targeted with specialized gear. A targeted fishery for flathead lobster could be set during the off months of the shrimp trawl fishery (February-July), reducing interference with the reproduction cycle.info:eu-repo/semantics/publishedVersio

Diversity, distribution, and density of marine mammals along the Saudi waters of the Arabian Gulf: update from a multi-method approach

Despite the important role of marine mammals in marine ecosystems and the imperative for their conservation, there is still a great lack of information on the diversity, distribution, and density of these animals in the Saudi waters of the Arabian Gulf. To fill this gap, an integrative data-collection approach including fishermen’s questionnaires, opportunistic sighting reports, and directed boat-based surveys, was undertaken between 2016 and 2020, leading to the first scientific report of marine mammal diversity, distribution, and density in the region. The results of the different approaches carried out during the study confirmed a high diversity of cetaceans on the west coast of the study area, with bottlenose dolphins (Tursiops aduncus), humpback dolphins (Sousa plumbea) and dugongs (Dugong dugon) as the most common species. While the two dolphin species were found to be widely distributed in both coastal and offshore waters, D. dugon appears to occur exclusively in coastal waters in the southern part of the study area, mainly in the Gulf of Salwah. The presence of both species of dolphins increased during the summer months and in the vicinity of the numerous oil and gas facilities in this region. The distribution of the observed dolphins was found mostly within a 10–20 km radius around each facility. Other cetacean species observed less frequently in the area include Bryde’s whale (Balaenoptera edeni), killer whale (Orcinus orca), common dolphin (Delphinus delphis) and finless porpoise (Neophocaena phocaenoides). Regarding the density of marine mammals in the region, boat-based surveys confirmed the results of fishermen’s questionnaires and reports of opportunistic sightings, with bottlenose and humpback dolphins being the most abundant species. These results provide a baseline for policies oriented to the conservation of mammals in the Saudi waters of the Arabian Gulf.info:eu-repo/semantics/publishedVersio

Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study

Background: While acute kidney injury (AKI) is a common complication in COVID-19, data on post-AKI kidney function recovery and the clinical factors associated with poor kidney function recovery is lacking. Methods: A retrospective multi-centre observational cohort study comprising 12,891 hospitalized patients aged 18 years or older with a diagnosis of SARS-CoV-2 infection confirmed by polymerase chain reaction from 1 January 2020 to 10 September 2020, and with at least one serum creatinine value 1–365 days prior to admission. Mortality and serum creatinine values were obtained up to 10 September 2021. Findings: Advanced age (HR 2.77, 95%CI 2.53–3.04, p < 0.0001), severe COVID-19 (HR 2.91, 95%CI 2.03–4.17, p < 0.0001), severe AKI (KDIGO stage 3: HR 4.22, 95%CI 3.55–5.00, p < 0.0001), and ischemic heart disease (HR 1.26, 95%CI 1.14–1.39, p < 0.0001) were associated with worse mortality outcomes. AKI severity (KDIGO stage 3: HR 0.41, 95%CI 0.37–0.46, p < 0.0001) was associated with worse kidney function recovery, whereas remdesivir use (HR 1.34, 95%CI 1.17–1.54, p < 0.0001) was associated with better kidney function recovery. In a subset of patients without chronic kidney disease, advanced age (HR 1.38, 95%CI 1.20–1.58, p < 0.0001), male sex (HR 1.67, 95%CI 1.45–1.93, p < 0.0001), severe AKI (KDIGO stage 3: HR 11.68, 95%CI 9.80–13.91, p < 0.0001), and hypertension (HR 1.22, 95%CI 1.10–1.36, p = 0.0002) were associated with post-AKI kidney function impairment. Furthermore, patients with COVID-19-associated AKI had significant and persistent elevations of baseline serum creatinine 125% or more at 180 days (RR 1.49, 95%CI 1.32–1.67) and 365 days (RR 1.54, 95%CI 1.21–1.96) compared to COVID-19 patients with no AKI. Interpretation: COVID-19-associated AKI was associated with higher mortality, and severe COVID-19-associated AKI was associated with worse long-term post-AKI kidney function recovery. Funding: Authors are supported by various funders, with full details stated in the acknowledgement section

Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study

Background: While acute kidney injury (AKI) is a common complication in COVID-19, data on post-AKI kidney function recovery and the clinical factors associated with poor kidney function recovery is lacking. Methods: A retrospective multi-centre observational cohort study comprising 12,891 hospitalized patients aged 18 years or older with a diagnosis of SARS-CoV-2 infection confirmed by polymerase chain reaction from 1 January 2020 to 10 September 2020, and with at least one serum creatinine value 1–365 days prior to admission. Mortality and serum creatinine values were obtained up to 10 September 2021. Findings: Advanced age (HR 2.77, 95%CI 2.53–3.04, p < 0.0001), severe COVID-19 (HR 2.91, 95%CI 2.03–4.17, p < 0.0001), severe AKI (KDIGO stage 3: HR 4.22, 95%CI 3.55–5.00, p < 0.0001), and ischemic heart disease (HR 1.26, 95%CI 1.14–1.39, p < 0.0001) were associated with worse mortality outcomes. AKI severity (KDIGO stage 3: HR 0.41, 95%CI 0.37–0.46, p < 0.0001) was associated with worse kidney function recovery, whereas remdesivir use (HR 1.34, 95%CI 1.17–1.54, p < 0.0001) was associated with better kidney function recovery. In a subset of patients without chronic kidney disease, advanced age (HR 1.38, 95%CI 1.20–1.58, p < 0.0001), male sex (HR 1.67, 95%CI 1.45–1.93, p < 0.0001), severe AKI (KDIGO stage 3: HR 11.68, 95%CI 9.80–13.91, p < 0.0001), and hypertension (HR 1.22, 95%CI 1.10–1.36, p = 0.0002) were associated with post-AKI kidney function impairment. Furthermore, patients with COVID-19-associated AKI had significant and persistent elevations of baseline serum creatinine 125% or more at 180 days (RR 1.49, 95%CI 1.32–1.67) and 365 days (RR 1.54, 95%CI 1.21–1.96) compared to COVID-19 patients with no AKI. Interpretation: COVID-19-associated AKI was associated with higher mortality, and severe COVID-19-associated AKI was associated with worse long-term post-AKI kidney function recovery. Funding: Authors are supported by various funders, with full details stated in the acknowledgement section